Anke Müller
- Safety profile and pharmacokinetics of SB010, an inhaled GATA-3-specific DNAzyme, in phase I clinical trials in healthy and asthmatic subjectsBy Ursula Homburg, Agnieszka Turowska, Jens Kuhlmann, Anke Müller, Jonas Renz, Joachim Bille, Harald Renz and Holger GarnUrsula Homburg1R&D, Sterna Biologicals GmbH & Co. KG, Marburg, GermanyAgnieszka Turowska1R&D, Sterna Biologicals GmbH & Co. KG, Marburg, GermanyJens Kuhlmann1R&D, Sterna Biologicals GmbH & Co. KG, Marburg, GermanyAnke Müller1R&D, Sterna Biologicals GmbH & Co. KG, Marburg, GermanyJonas Renz1R&D, Sterna Biologicals GmbH & Co. KG, Marburg, GermanyJoachim Bille1R&D, Sterna Biologicals GmbH & Co. KG, Marburg, GermanyHarald Renz2Institute of Laboratory Medicine and Pathobiochemistry, Philipps University of Marburg, Marburg, GermanyHolger Garn2Institute of Laboratory Medicine and Pathobiochemistry, Philipps University of Marburg, Marburg, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.